<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
placeholder

Future 'Exceedingly Bright' for Kidney Stone Prevention

Default sub title

minute read

Written by Medscape on September 13, 2021

"The majority of patients who received lumasiran had normal or near-normal levels after 6 months of treatment," those investigators report.

Topics: Press Coverage

Related Stories